GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celltrion Pharm Inc (XKRX:068760) » Definitions » Change In Receivables

Celltrion Pharm (XKRX:068760) Change In Receivables : ₩13,213 Mil (TTM As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Celltrion Pharm Change In Receivables?

Celltrion Pharm's change in receivables for the quarter that ended in Mar. 2025 was ₩27,998 Mil. It means Celltrion Pharm's Accounts Receivable declined by ₩27,998 Mil from Dec. 2024 to Mar. 2025 .

Celltrion Pharm's change in receivables for the fiscal year that ended in Dec. 2024 was ₩8,620 Mil. It means Celltrion Pharm's Accounts Receivable declined by ₩8,620 Mil from Dec. 2023 to Dec. 2024 .

Celltrion Pharm's Accounts Receivable for the quarter that ended in Mar. 2025 was ₩187,893 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Celltrion Pharm's Days Sales Outstanding for the three months ended in Mar. 2025 was 152.37.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Celltrion Pharm's liquidation value for the three months ended in Mar. 2025 was ₩16,883 Mil.


Celltrion Pharm Change In Receivables Historical Data

The historical data trend for Celltrion Pharm's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Pharm Change In Receivables Chart

Celltrion Pharm Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,064.45 -31,686.70 -13,707.35 -34,894.12 8,620.10

Celltrion Pharm Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,405.15 -4,629.43 9,245.25 -19,400.87 27,998.45

Celltrion Pharm Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩13,213 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celltrion Pharm  (XKRX:068760) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Celltrion Pharm's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=187892.929/112523.998*91
=152.37

2. In Ben Graham's calculation of liquidation value, Celltrion Pharm's accounts receivable are only considered to be worth 75% of book value:

Celltrion Pharm's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=97212.18-273622.801+0.75 * 187892.929+0.5 * 104747.03
=16,883

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celltrion Pharm Change In Receivables Related Terms

Thank you for viewing the detailed overview of Celltrion Pharm's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Celltrion Pharm Business Description

Traded in Other Exchanges
N/A
Address
17Floor, LG Dacom Building, 706-1 Yeoksam-dong, Kangnamgu, Seoul, KOR, 130-987
Celltrion Pharm Inc is active in the Korean healthcare sector. Its core business includes the manufacture and sale of pharmaceuticals such as heptatonic, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs and antibiotics.

Celltrion Pharm Headlines

No Headlines